Lucas Wong Selected Research

Neoplasms (Cancer)

1/2024	The use of cannabinoids in palliating cancer-related symptoms: a narrative review.
9/2023	Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer.
1/2023	The Texas Immuno-Oncology Biorepository, a statewide biospecimen collection and clinical informatics system to enable longitudinal tumor and immune profiling.
1/2022	4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone provokes progression from chronic pancreatitis to pancreatic intraepithelial neoplasia.
1/2020	NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer.
1/2020	A randomized trial of nurse-administered behavioral interventions to manage anticipatory nausea and vomiting in chemotherapy.
1/2017	Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC.
1/2016	Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630.
1/2016	Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.
12/2013	Phase 2, multicenter, open-label study of tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy-naive patients with unresectable or metastatic pancreatic cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucas Wong Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 09/2002
6	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 07/2008
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2013
3	Nausea 01/2024 - 12/2013
3	Adenocarcinoma 09/2023 - 11/2004
2	Vomiting 01/2024 - 01/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 02/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 09/2002
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2014
2	Diarrhea 03/2015 - 07/2008
1	Anorexia 01/2024
1	Cancer Pain 01/2024
1	Cachexia 01/2024
1	Chronic Pancreatitis 01/2022
1	Anticipatory Vomiting 01/2020
1	Disease Progression 01/2017
1	Hyperplasia 01/2016
1	Cholangiocarcinoma 01/2016
1	Edema (Dropsy) 12/2013
1	Fatigue 12/2013
1	Leukemia 10/2012
1	Heart Diseases (Heart Disease) 10/2009
1	Carcinogenesis 05/2009
1	Dehydration (Water Stress) 07/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2007
1	Plasma Cell Leukemia 12/2005
1	Multiple Myeloma 12/2005
1	Tumor Lysis Syndrome 12/2005
1	Drug-Related Side Effects and Adverse Reactions 12/2005
1	Cytopenia 01/2005
1	Squamous Cell Carcinoma of Head and Neck 01/2005
1	Carcinoma (Carcinomatosis) 01/2005
1	Colonic Neoplasms (Colon Cancer) 11/2004
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 08/2004
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 09/2002

Drug/Important Bio-Agent (IBA)

3	Monoclonal AntibodiesIBA 12/2013 - 11/2004
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 07/2008
2	Leucovorin (Folinic Acid)FDA Link 04/2024 - 04/2017
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2024 - 03/2015
2	pembrolizumabIBA 04/2024 - 04/2024
2	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 01/2018 - 05/2007
2	Gemcitabine FDA Link 01/2018 - 12/2013
2	CaspasesIBA 12/2013 - 05/2009
2	beta CateninIBA 05/2009 - 08/2004
2	PPAR gammaIBA 05/2009 - 08/2004
1	Fluorouracil (Carac)FDA LinkGeneric 04/2024
1	binimetinibIBA 04/2024
1	Dronabinol (THC)FDA LinkGeneric 01/2024
1	CannabinoidsIBA 01/2024
1	O-(6)-methylguanineIBA 09/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2022
1	ResveratrolIBA 01/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	olaratumabIBA 01/2017
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2016
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2016
1	Histidine DecarboxylaseIBA 01/2016
1	Tamoxifen FDA LinkGeneric 01/2016
1	Tolonium Chloride FDA Link 01/2016
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2016
1	Stem Cell FactorIBA 01/2016
1	Calcium AluminosilicateIBA 03/2015
1	Filgrastim (Neupogen)FDA Link 01/2014
1	taxaneIBA 01/2014
1	Docetaxel (Taxotere)FDA Link 01/2014
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2014
1	tigatuzumabIBA 12/2013
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2013
1	Single-Chain AntibodiesIBA 10/2012
1	Bispecific AntibodiesIBA 10/2012
1	Immunoglobulin G (IgG)IBA 10/2012
1	bavituximabIBA 11/2011
1	PhosphatidylserinesIBA 11/2011
1	romidepsin (FK228)FDA Link 10/2009
1	Troglitazone (Rezulin)FDA Link 05/2009
1	LigandsIBA 05/2009
1	Proteins (Proteins, Gene)FDA Link 05/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009
1	Bevacizumab (Avastin)FDA Link 07/2008
1	Capecitabine (Xeloda)FDA Link 07/2008
1	Glycogen Synthase Kinase 3IBA 10/2007
1	Peptides (Polypeptides)IBA 12/2005
1	Immunotoxins (Immunotoxin)IBA 12/2005
1	Proteasome InhibitorsIBA 12/2005
1	Bortezomib (Velcade)FDA Link 12/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2004
1	Glycogen Synthase Kinase 3 betaIBA 08/2004
1	Glycogen Synthase KinasesIBA 08/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2004
1	Carboplatin (JM8)FDA LinkGeneric 10/2003
1	Ifosfamide FDA LinkGeneric 10/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2003

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 04/2024 - 09/2002
5	Therapeutics 01/2022 - 11/2004
2	Neoadjuvant Therapy 09/2023 - 01/2005
1	Chemoradiotherapy 09/2023
1	Oral Administration 03/2015
1	Drug Tapering 07/2008
1	Radiotherapy 01/2005